Selected research
Industry Research
AI Drug Discovery Platform Industry Research Report 2026
Market perspective
The global AI Drug Discovery Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI Drug Discovery Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI Drug Discovery Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI Drug Discovery Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI Drug Discovery Platform include Exscientia, Iktos, Delta4, Healx, Innoplexus, BenevolentAI, Evaxion, Genome Biologics and Novadiscovery, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI Drug Discovery Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI Drug Discovery Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI Drug Discovery Platform Market by Company
Exscientia
Iktos
Delta4
Healx
Innoplexus
BenevolentAI
Evaxion
Genome Biologics
Novadiscovery
Nuritas
CytoReason
Turbine Simulated Cell Technologies
Atomwise
Recursion
Insilico Medicine
Relay Therapeutics
Pfizer
Janssen
AstraZeneca
Beijing Iipharma
AI Drug Discovery Platform Segment by Type
Drug Discovery
Drug Design
AI Drug Discovery Platform Segment by Application
Pharmaceutical Company
Biotech Company
Contract Research Organization
Others
AI Drug Discovery Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Drug Discovery Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Discovery
- Drug Design
Applications
- Pharmaceutical Company
- Biotech Company
- Contract Research Organization
- Others
Companies covered
- Exscientia
- Iktos
- Delta4
- Healx
- Innoplexus
- BenevolentAI
- Evaxion
- Genome Biologics
- Novadiscovery
- Nuritas
- CytoReason
- Turbine Simulated Cell Technologies
- Atomwise
- Recursion
- Insilico Medicine
- Relay Therapeutics
- Pfizer
- Janssen
- AstraZeneca
- Beijing Iipharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI Drug Discovery Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Drug Discovery
- 2.2.3 Drug Design
- 2.3 AI Drug Discovery Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Company
- 2.3.3 Biotech Company
- 2.3.4 Contract Research Organization
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 AI Drug Discovery Platform Breakdown Data by Type
- 3.1 Global AI Drug Discovery Platform Historic Market Size by Type (2021-2026)
- 3.2 Global AI Drug Discovery Platform Forecasted Market Size by Type (2027-2032)
4 AI Drug Discovery Platform Breakdown Data by Application
- 4.1 Global AI Drug Discovery Platform Historic Market Size by Application (2021-2026)
- 4.2 Global AI Drug Discovery Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI Drug Discovery Platform Market Perspective (2021-2032)
- 5.2 Global AI Drug Discovery Platform Growth Trends by Region
- 5.2.1 Global AI Drug Discovery Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI Drug Discovery Platform Historic Market Size by Region (2021-2026)
- 5.2.3 AI Drug Discovery Platform Forecasted Market Size by Region (2027-2032)
- 5.3 AI Drug Discovery Platform Market Dynamics
- 5.3.1 AI Drug Discovery Platform Industry Trends
- 5.3.2 AI Drug Discovery Platform Market Drivers
- 5.3.3 AI Drug Discovery Platform Market Challenges
- 5.3.4 AI Drug Discovery Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI Drug Discovery Platform Players by Revenue
- 6.1.1 Global Top AI Drug Discovery Platform Players by Revenue (2021-2026)
- 6.1.2 Global AI Drug Discovery Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global AI Drug Discovery Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI Drug Discovery Platform Head Office and Area Served
- 6.4 Global AI Drug Discovery Platform Players, Product Type & Application
- 6.5 Global AI Drug Discovery Platform Manufacturers Established Date
- 6.6 Global AI Drug Discovery Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI Drug Discovery Platform Market Size (2021-2032)
- 7.2 North America AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI Drug Discovery Platform Market Size by Country (2021-2026)
- 7.4 North America AI Drug Discovery Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI Drug Discovery Platform Market Size (2021-2032)
- 8.2 Europe AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI Drug Discovery Platform Market Size by Country (2021-2026)
- 8.4 Europe AI Drug Discovery Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI Drug Discovery Platform Market Size (2021-2032)
- 9.2 Asia-Pacific AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI Drug Discovery Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI Drug Discovery Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI Drug Discovery Platform Market Size (2021-2032)
- 10.2 South America AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI Drug Discovery Platform Market Size by Country (2021-2026)
- 10.4 South America AI Drug Discovery Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI Drug Discovery Platform Market Size (2021-2032)
- 11.2 Middle East & Africa AI Drug Discovery Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI Drug Discovery Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI Drug Discovery Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Exscientia
- 12.1.1 Exscientia Company Information
- 12.1.2 Exscientia Business Overview
- 12.1.3 Exscientia Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.1.4 Exscientia AI Drug Discovery Platform Product Portfolio
- 12.1.5 Exscientia Recent Developments
- 12.2 Iktos
- 12.2.1 Iktos Company Information
- 12.2.2 Iktos Business Overview
- 12.2.3 Iktos Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.2.4 Iktos AI Drug Discovery Platform Product Portfolio
- 12.2.5 Iktos Recent Developments
- 12.3 Delta4
- 12.3.1 Delta4 Company Information
- 12.3.2 Delta4 Business Overview
- 12.3.3 Delta4 Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.3.4 Delta4 AI Drug Discovery Platform Product Portfolio
- 12.3.5 Delta4 Recent Developments
- 12.4 Healx
- 12.4.1 Healx Company Information
- 12.4.2 Healx Business Overview
- 12.4.3 Healx Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.4.4 Healx AI Drug Discovery Platform Product Portfolio
- 12.4.5 Healx Recent Developments
- 12.5 Innoplexus
- 12.5.1 Innoplexus Company Information
- 12.5.2 Innoplexus Business Overview
- 12.5.3 Innoplexus Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.5.4 Innoplexus AI Drug Discovery Platform Product Portfolio
- 12.5.5 Innoplexus Recent Developments
- 12.6 BenevolentAI
- 12.6.1 BenevolentAI Company Information
- 12.6.2 BenevolentAI Business Overview
- 12.6.3 BenevolentAI Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.6.4 BenevolentAI AI Drug Discovery Platform Product Portfolio
- 12.6.5 BenevolentAI Recent Developments
- 12.7 Evaxion
- 12.7.1 Evaxion Company Information
- 12.7.2 Evaxion Business Overview
- 12.7.3 Evaxion Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.7.4 Evaxion AI Drug Discovery Platform Product Portfolio
- 12.7.5 Evaxion Recent Developments
- 12.8 Genome Biologics
- 12.8.1 Genome Biologics Company Information
- 12.8.2 Genome Biologics Business Overview
- 12.8.3 Genome Biologics Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.8.4 Genome Biologics AI Drug Discovery Platform Product Portfolio
- 12.8.5 Genome Biologics Recent Developments
- 12.9 Novadiscovery
- 12.9.1 Novadiscovery Company Information
- 12.9.2 Novadiscovery Business Overview
- 12.9.3 Novadiscovery Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.9.4 Novadiscovery AI Drug Discovery Platform Product Portfolio
- 12.9.5 Novadiscovery Recent Developments
- 12.10 Nuritas
- 12.10.1 Nuritas Company Information
- 12.10.2 Nuritas Business Overview
- 12.10.3 Nuritas Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.10.4 Nuritas AI Drug Discovery Platform Product Portfolio
- 12.10.5 Nuritas Recent Developments
- 12.11 CytoReason
- 12.11.1 CytoReason Company Information
- 12.11.2 CytoReason Business Overview
- 12.11.3 CytoReason Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.11.4 CytoReason AI Drug Discovery Platform Product Portfolio
- 12.11.5 CytoReason Recent Developments
- 12.12 Turbine Simulated Cell Technologies
- 12.12.1 Turbine Simulated Cell Technologies Company Information
- 12.12.2 Turbine Simulated Cell Technologies Business Overview
- 12.12.3 Turbine Simulated Cell Technologies Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.12.4 Turbine Simulated Cell Technologies AI Drug Discovery Platform Product Portfolio
- 12.12.5 Turbine Simulated Cell Technologies Recent Developments
- 12.13 Atomwise
- 12.13.1 Atomwise Company Information
- 12.13.2 Atomwise Business Overview
- 12.13.3 Atomwise Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.13.4 Atomwise AI Drug Discovery Platform Product Portfolio
- 12.13.5 Atomwise Recent Developments
- 12.14 Recursion
- 12.14.1 Recursion Company Information
- 12.14.2 Recursion Business Overview
- 12.14.3 Recursion Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.14.4 Recursion AI Drug Discovery Platform Product Portfolio
- 12.14.5 Recursion Recent Developments
- 12.15 Insilico Medicine
- 12.15.1 Insilico Medicine Company Information
- 12.15.2 Insilico Medicine Business Overview
- 12.15.3 Insilico Medicine Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.15.4 Insilico Medicine AI Drug Discovery Platform Product Portfolio
- 12.15.5 Insilico Medicine Recent Developments
- 12.16 Relay Therapeutics
- 12.16.1 Relay Therapeutics Company Information
- 12.16.2 Relay Therapeutics Business Overview
- 12.16.3 Relay Therapeutics Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.16.4 Relay Therapeutics AI Drug Discovery Platform Product Portfolio
- 12.16.5 Relay Therapeutics Recent Developments
- 12.17 Pfizer
- 12.17.1 Pfizer Company Information
- 12.17.2 Pfizer Business Overview
- 12.17.3 Pfizer Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.17.4 Pfizer AI Drug Discovery Platform Product Portfolio
- 12.17.5 Pfizer Recent Developments
- 12.18 Janssen
- 12.18.1 Janssen Company Information
- 12.18.2 Janssen Business Overview
- 12.18.3 Janssen Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.18.4 Janssen AI Drug Discovery Platform Product Portfolio
- 12.18.5 Janssen Recent Developments
- 12.19 AstraZeneca
- 12.19.1 AstraZeneca Company Information
- 12.19.2 AstraZeneca Business Overview
- 12.19.3 AstraZeneca Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.19.4 AstraZeneca AI Drug Discovery Platform Product Portfolio
- 12.19.5 AstraZeneca Recent Developments
- 12.20 Beijing Iipharma
- 12.20.1 Beijing Iipharma Company Information
- 12.20.2 Beijing Iipharma Business Overview
- 12.20.3 Beijing Iipharma Revenue in AI Drug Discovery Platform Business (2021-2026)
- 12.20.4 Beijing Iipharma AI Drug Discovery Platform Product Portfolio
- 12.20.5 Beijing Iipharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst